Lithium‐induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue
- 10 July 2009
- journal article
- Published by Wiley in Bipolar Disorders
- Vol. 11 (5), 515-522
- https://doi.org/10.1111/j.1399-5618.2009.00729.x
Abstract
Objectives: Extensive preclinical and clinical evidence suggests mitochondrial dysfunction in bipolar disorder. Studies of brain energy metabolism in bipolar disorder suggest an impairment of energy generation by mitochondrial oxidative phosphorylation. Lithium is an effective drug widely used in treating bipolar disorder, but its mechanism of action has remained uncertain. The aim of this study was to clarify the effect of lithium on mitochondrial oxidative phosphorylation. Methods: We spectrophotometrically determined the activities of the respiratory chain complexes I + III [antimycin A-sensitive nicotinamide adenine dinucleotide (NADH) cytochrome c oxidorductase], complexes II + III (succinate cytochrome c oxidoreductase), succinate dehydrogenase, and complex IV [cytochrome c oxidase (COX)], and of the mitochondrial matrix enzyme citrate synthase in postmortem human brain cortex homogenates following exposure to lithium (up to 10 mM). Results: Activities of complexes I + III and of complexes II + III were dose-dependently increased by lithium with maximum values at 1 mM (165%, p = 0.03, and 146%, p = 0.00002, of controls). Activity of succinate dehydrogenase remained unchanged up to 2 mM, but was raised at higher drug concentrations (maximum 220%, p = 0.01, of controls). In contrast, activity of COX was not significantly affected by the drug (decrease of 12% at 1 mM, p = 0.4). Conclusions: Our study suggests that lithium stimulates mitochondrial respiratory chain enzyme activities at clinically relevant concentrations. Lithium’s effect on the mitochondrial respiratory chain presents further evidence of the pathophysiological significance of mitochondrial dysfunction in bipolar disorder. The effect may be relevant to the therapeutic efficacy of the drug by potentially reversing a disease-related alteration.Keywords
This publication has 42 references indexed in Scilit:
- Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar DisorderNeuropsychopharmacology, 2008
- Lithium Desensitizes Brain Mitochondria to Calcium, Antagonizes Permeability Transition, and Diminishes Cytochrome c ReleasePublished by Elsevier BV ,2007
- Brain-to-Serum Lithium Ratio and Age: An In Vivo Magnetic Resonance Spectroscopy StudyAmerican Journal of Psychiatry, 2002
- Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithiumBrain Research, 2001
- Chronic Lithium Treatment Decreases Neuronal Activity in the Nucleus Accumbens and Cingulate Cortex of the RatNeuropsychopharmacology, 1999
- Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser ResidueJournal of Neurochemistry, 1995
- Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopyJournal of Affective Disorders, 1994
- Lithium Induces Apoptosis in Immature Cerebellar Granule Cells but Promotes Survival of Mature NeuronsExperimental Cell Research, 1994
- Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopyJournal of Affective Disorders, 1993
- Lithium Studies. 3. Distribution between Serum and Tissues.Acta Pharmacologica et Toxicologica, 1958